Effects of Light on Melatonin and Contractions in Pregnant Women
NCT ID: NCT01863446
Last Updated: 2024-08-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2013-05-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary aim. Test the hypothesis that ocular light exposure will reduce self-reported uterine contractions in women at late term pregnancies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Children's Books to Brochures for Safe Sleep and Infant Reading Education During Prenatal Care
NCT04031235
The Role of Oxytocin in the Perception of Faces
NCT02443727
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study
NCT00649961
Intranasal Oxytocin and Maternal Neglect
NCT02737436
Promoting Mother-Baby Bonding Through a Relaxation Routine During Pregnancy
NCT02943083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lighting1
Ocular light exposure of a red wavelength light for one night
Lighting1
Ocular light exposure to a red wavelength light
Lighting2
Ocular light exposure of a blue-green wavelength light for one night
Lighting2
Ocular light exposure to a blue/green wavelength light
Lighting3
Ocular light exposure to a red wavelength light on night 1 and to a red wavelength light on night 2
Lighting1
Ocular light exposure to a red wavelength light
Lighting4
Ocular light exposure to a red wavelength light on night 1 and to a blue-green wavelength light on night 2
Lighting1
Ocular light exposure to a red wavelength light
Lighting2
Ocular light exposure to a blue/green wavelength light
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lighting1
Ocular light exposure to a red wavelength light
Lighting2
Ocular light exposure to a blue/green wavelength light
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* first pregnancy
Exclusion Criteria
* twin or higher pregnancy
* using medication that affects the sympathetic nervous system
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard University
OTHER
National Institutes of Health (NIH)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elizabeth Klerman MD PhD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth B Klerman, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham and Women's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012P002568
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.